[Federal Register Volume 84, Number 248 (Friday, December 27, 2019)]
[Notices]
[Page 71435]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27860]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2020-1: 
Reagents for Immunologic Analysis of Non-Mammalian and 
Underrepresented Mammalian Models (Topic 083).
    Date: January 21, 2020.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Ann Marie M. Brighenti, Ph.D., Scientific Review 
Officer, Program Management & Operations Branch, Division of 
Extramural Activities, Scientific Review Program, Room 3E71, 
National Institutes of Health, National Institutes of Allergy and 
Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852, 301-
761-3100, mailto:[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: December 19, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-27860 Filed 12-26-19; 8:45 am]
 BILLING CODE 4140-01-P